EGFR and non-small cell lung carcinoma: Meanwhile, some studies using surgical samples of chemo-naïve NSCLC have shown lower PD-L1 expression in EGFR-mutant NSCLC than in EGFR wild-type, as we have demonstrated [13, 14].